ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,461,098, issued on Nov. 4, was assigned to GLX Analytix ApS (Copenhagen, Denmark).
"Biomarkers for multiple sclerosis" was invented by Brian William Della Valle (Copenhagen, Denmark), Casper Hempel (Dyssegard, Denmark) and Marie Agnete Larsen (Hinnerup, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are biomarkers for the prediction of the risk of developing and/or having multiple sclerosis (MS), as well as staging/subtyping MS and methods for evaluating treatment protocols for MS and for assisting in the prognosis of MS. Also described herein are biomarkers associated with multiple sclerosis (MS), particular GLX molecules, and e...